Bosh sahifaONCY • NASDAQ
add
Oncolytics Biotech Inc
0,99 $
Seans yopilganidan keyin:(1,54%)-0,015
0,98 $
Yopilgan:5-dek, 18:45:54 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
0,98 $
Kunlik diapazon
0,95 $ - 1,01 $
Yillik diapazon
0,33 $ - 1,51 $
Bozor kapitalizatsiyasi
96,71 mln USD
Oʻrtacha hajm
863,77 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CAD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 13,84 mln | 39,81% |
Sof foyda | -14,40 mln | -50,90% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -0,14 | -16,67% |
EBITDA | -13,82 mln | -40,08% |
Amaldagi soliq stavkasi | 1,72% | — |
Balans
Jami aktivlari
Jami passivlari
| (CAD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 12,35 mln | -36,97% |
Jami aktivlari | 15,06 mln | -37,94% |
Jami passivlari | 14,94 mln | -1,73% |
Umumiy kapital | 115,00 ming | — |
Tarqatilgan aksiyalar | 106,15 mln | — |
Narxi/balansdagi bahosi | ∞ | — |
Aktivlardan daromad | -197,54% | — |
Kapitaldan daromad | -872,97% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CAD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -14,40 mln | -50,90% |
Operatsiyalardan naqd pul | -6,65 mln | -37,64% |
Sarmoyadan naqd pul | -7,00 ming | 78,12% |
Moliyadan naqd pul | 4,14 mln | 2 491,91% |
Naqd pulning sof oʻzgarishi | -2,27 mln | 56,70% |
Boʻsh pul | -765,00 ming | 55,05% |
Haqida
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Tashkil etilgan
1998
Bosh ofis
Xodimlar soni
28
